Xingming Deng
Impact in
- Molecular Biology top 1%
- Cell death mechanisms and regulation
- Protein Kinase Regulation and GTPase Signaling
- RNA Interference and Gene Delivery
- Ubiquitin and proteasome pathways
- PI3K/AKT/mTOR signaling in cancer
- DNA Repair Mechanisms
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- Cell death mechanisms and regulation 37
- DNA Repair Mechanisms 17
- Protein Kinase Regulation and GTPase Signaling 16
- Cancer therapeutics and mechanisms 12
- PI3K/AKT/mTOR signaling in cancer 8
- Ubiquitin and proteasome pathways 6
- Oncology 37
- Cancer-related Molecular Pathways 15
- PARP inhibition in cancer therapy 6
- Co-authors
- W. Stratford May (21 shared papers)Boyd K. Carr (5 shared papers)Fengqin Gao (17 shared papers)Peter P. Ruvolo (7 shared papers)Takahiko Ito (3 shared papers)Meiguo Xin (6 shared papers)Tammy Flagg (11 shared papers)Fadlo R. Khuri (21 shared papers)
- Journals
- Journal of Biological Chemistry (21 papers)Cancer Research (7 papers)Blood (5 papers)Nature Communications (4 papers)PLoS ONE (3 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Xingming Deng
104 papers receiving 7.4k citations
Peers
Comparison fields: 5 of 139
- Molecular Biology 5.2k
- Oncology 1.7k
- Cancer Research 920
- Cell Biology 835
- Toxicology 133
Countries citing papers authored by Xingming Deng
This map shows the geographic impact of Xingming Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingming Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingming Deng more than expected).
Fields of papers citing papers by Xingming Deng
This network shows the impact of papers produced by Xingming Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingming Deng. The network helps show where Xingming Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xingming Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 474 | |
| 2 | 2001 | 414 | |
| 3 | 1998 | 397 | |
| 4 | 1999 | 293 | |
| 5 | 2001 | 249 | |
| 6 | 2003 | 249 | |
| 7 | 2000 | 218 | |
| 8 | 2005 | 198 | |
| 9 | 2012 | 172 | |
| 10 | 2013 | 148 | |
| 11 | 2010 | 145 | |
| 12 | 2003 | 132 | |
| 13 | 2013 | 130 | |
| 14 | 2018 | 124 | |
| 15 | 2003 | 120 | |
| 16 | 2006 | 117 | |
| 17 | 1998 | 115 | |
| 18 | 2003 | 112 | |
| 19 | 2004 | 111 | |
| 20 | 2006 | 111 |
About Xingming Deng
Xingming Deng is a scholar working on Molecular Biology, Oncology, Cell Biology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 105 papers that have together received 7.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (37 papers), DNA Repair Mechanisms (17 papers), Protein Kinase Regulation and GTPase Signaling (16 papers), Cancer-related Molecular Pathways (15 papers), Cancer therapeutics and mechanisms (12 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Ubiquitin and proteasome pathways (6 papers) and PARP inhibition in cancer therapy (6 papers). The work is most often cited by research in Molecular Biology (5.2k citations), Oncology (1.7k citations), Cancer Research (920 citations), Cell Biology (835 citations) and Toxicology (133 citations). Xingming Deng has collaborated with scholars based in United States, China and Japan. Frequent co-authors include W. Stratford May, Boyd K. Carr, Fengqin Gao, Peter P. Ruvolo, Takahiko Ito, Meiguo Xin, Tammy Flagg, Fadlo R. Khuri, Lijun Xu and Taofeek K. Owonikoko. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Blood, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.